Gastroenterology - Fatty liver disease linked to higher risk of heart attacks
View as a Web Page
News Medical
 
  Gastroenterology Gastroenterology logo  
  The latest gastroenterology‎ news from News Medical  
 

Hydrogen–Methane Breath Testing: The Gut’s ThermometerHydrogen–Methane Breath Testing: The Gut’s Thermometer

Hydrogen and methane breath testing acts like a thermometer for gut activity, showing how microbes respond to food and drink. Dr Jafari explains how nutrition and hydration influence digestive processes, highlighting their daily interaction and combined role in maintaining gut function and digestive system health in the human body today.

What Is Your Gut Saying?
 
   Fatty liver disease linked to higher risk of heart attacksFatty liver disease linked to higher risk of heart attacks
 
Researchers at Mass General Brigham Heart and Vascular Institute found that people with hepatic steatosis, commonly called "fatty liver disease," have a higher amount of noncalcified, rupture-prone coronary plaque and face nearly twice the rate of cardiovascular events compared to those without steatosis.
 
   New gene expression signature may guide immunotherapy for resistant prostate cancer patientsNew gene expression signature may guide immunotherapy for resistant prostate cancer patients
 
Researchers with the James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center have discovered a new gene expression signature within tumors that can help identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are more likely to experience lasting benefits from combined immunotherapy treatment.
 
   New Data Suggest Ready-to-Eat Meats Rarely Reach Illness-Linked Bacterial LevelsNew Data Suggest Ready-to-Eat Meats Rarely Reach Illness-Linked Bacterial Levels
 
The study found that Clostridium perfringens was occasionally detected in raw or not-ready-to-eat meat products, but rarely appeared at concerning levels in cooked ready-to-eat meats. Even products linked to cooling deviations did not exceed 2 log CFU/g, suggesting that illness-associated growth during commercial stabilization is highly unlikely.
 
   Study Reveals New Biological Pathway for TNF-Resistant Crohn’s DiseaseStudy Reveals New Biological Pathway for TNF-Resistant Crohn’s Disease
 
Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly used therapies.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026